News

This new agreement will use BioFocus’s high throughput screening expertise to discover compounds that ‘hit’ nuclear hormone receptors (NHRs). Under the terms of the agreement, BioFocus will receive

The grant entails a collaborative effort between researchers at Micronics and the Seattle Children’s Research Institute (SCRI), in which a novel primer design method that enables detection of

The letter indicated that Glumetza is approvable pending the completion of discussions about finalizing a manufacturing specification. Biovail anticipates submitting a response to the FDA in the coming

Valeant acquired Tasmar (tolcapone) from Roche and re-launched the product in the US and other countries throughout the rest of the world in the summer of 2004. Tasmar

Four sites have been selected to conduct Samaritan’s trial for HIV-infected patients experiencing resistance to antiretroviral therapy. In addition, internal review boards responsible for protecting study patients have

This new human clinical study will evaluate the potential of MPC-6827 to treat metastatic brain cancer by achieving therapeutic concentrations in the brain that are sufficient to treat

The National Institute of Clinical Excellence (NICE) has recommended that four cholinesterase inhibitors currently licensed in the UK for use in Alzheimer’s disease, donepezil (Pfizer and Eisai’s Aricept),

Under the terms of this agreement, 3M and Takeda will share further costs of development and, upon successful clinical development and regulatory approvals, the companies will jointly commercialize

Increased platelet activation is a feature of diabetes that contributes to the high incidence of cardiovascular events in diabetic patients. NCX 4016 is a novel antithrombotic and vascular